In this murine (BALB/c) model of necatoriasis, high levels of protection against challenge infection by Necator americanus larvae (n = 300) were afforded by successive vaccinations at 14-day intervals, either subcutaneously or percutaneously, with γ-irradiated N. americanus larvae (n = 300). Percutaneous vaccination was significantly more effective than the subcutaneous route, with pulmonary larval 
Introduction
Despite the wide range of antihelminthic treatments available, the prevalence of hookworm infection remains a major public health concern. The requirement for repeated doses, the development of drug-resistant strains and the risk of re-infection are the main limitations of chemotherapeutic intervention (Quinnell et al., 1993; Hotez and Pritchard, 1995) . The development of a vaccine, providing life-long protection, thus represents an attractive and necessary solution to this problem; as such, the Sabin Vaccine Institute's hookworm vaccine initiative has been developed.
Some of the more successful vaccines developed have used attenuated organisms, attenuation providing the immune system with the prolonged antigen exposure necessary for the development of protective immunity. There are several ways of attenuating infective organisms, and irradiation has been successful in animal models against a range of parasites, such as Plasmodium berghei (Nussenweig et al., 1998) , Leishmania major (Rivier et al., 1993) , Toxoplasma gondii (Dubey et al., 1996) , Schistosoma mansoni (Smythies et al., 1996) and the nematodes Heligmosomoides polygyrus (Hagan et al., 1981) , Strongylus vulgaris (Clifton et al., 1997) and Ancylostoma caninum (Miller, 1971) . Despite this success and abundant evidence to indicate that the resistance displayed by mice vaccinated with irradiated parasites is mediated by specific immune mechanisms, few irradiation-attenuated vaccines are commercially available. Vaccines based on attenuated larvae suffer from a number of problems including a short shelf-life and the establishment of a degree of infection.
Notwithstanding, useful insights may be learnt from using irradiated larvae as vaccines, including the immunological compartment(s) participating in immunity, the site of larval attrition and the kinetics of protective responses. Such information will aid the development of successful vaccines and the types of adjuvant which should be administered with these vaccines.
The current paper describes the establishment of a successful vaccine model for Necator americanus, exploiting the immunogenicity of irradiated larvae in BALB/c mice. Furthermore, data are presented to indicate the immunological phenotype of the successfully protected vaccine recipient.
Materials and Methods

Preparation of third stage infective larvae
Necator americanus was maintained in syngeneic DSN hamsters, as described by Sen and Seth (1967) and the third stage infective larvae cultured from faecal material by a method modified from Harada and Mori (1955) , previously described by Kumar and Pritchard (1992) . Third stage infective larvae were harvested, concentrated and resuspended in 50 mM Na 2 HPO4, 70 mM NaCl, 15 mM KH 2 PO4, pH 7.4 for immediate use. Harvested larvae were exposed to 40 kilorads of γ-radiation from a sealed 137 Cs source and used in vaccination experiments within 2 h of irradiation.
N. americanus larval excretory/secretory (ES) products
Freshly collected third stage larvae were exsheathed by bubbling carbon dioxide through the larval suspension for 1 h at room temperature. Exsheathed larvae were allowed to settle and then washed extensively with phenol-red free RPMI 1640 containing 100 IU/ml of penicillin, 100 µg/ml of streptomycin, and 1 % (w/v) amphotericin B (final concentrations) under sterile conditions. Following sterilisation, the larvae were then cultured in RPMI 1640 containing the above additives for 72 h at 37 ºC, changing the culture medium every 24 h. ES products collected over the 72 h period were pooled, dialysed against distilled water and stored a -20 ºC until required.
The protein concentration was estimated using the Bio-Rad protein assay kit, with BSA standards.
Vaccination
Male BALB/c mice (Harlan Ltd UK) were vaccinated three times either s.c. or percutaneously (experiment 1), or two times percutaneously (experiment 2), 14 days apart, with 300 γ-irradiated N. americanus larvae (Behnke et al., 1986) . For s.c, immunistaion 0.1ml sterile pyrogen free water containing the larvae was injected using a 25G needle at the nape of the neck. For percutaneous immunisation, mice were anaesthetised by i.p. injection of Sagatal and shaved around the neck. Larvae were applied to the skin on a gauze, held in place for 24 h to allow larval penetration.
Gauze without larvae was used to treat control ('non-vaccinated') animals. Two weeks after the final vaccination, mice were challenged ('infected') with 300 normal N. americanus larvae. Naïve animals were neither vaccinated nor infected. Each experimental group consisted of six animals.
Quantification of parasite burden
Larvae were recovered post-mortem from the lungs on day 3 p.i. (or days 1 to 10 in the study of larval migration through the lungs) and from the small intestine on days 8 or 9 p.i., as described by Wells and Behnke (1988) .
The lungs were finely chopped, placed in pre-warmed Hanks buffered salt solution (HBSS) and incubated for 8 h at 37 °C. Every 2 h, HBSS was collected and replaced with fresh warm HBSS and the lungs were further chopped. The numbers of worms in pooled incubate were counted.
The small intestine was opened along its length on a nylon gauze. The gauze was suspended in pre-warmed HBSS and incubated for 6 h allowing L 4 larvae to sediment.
The gauze was then removed, excess HBSS was aspirated and the sedimented L 4 larvae were counted.
Serum immunoglobulins
At time points when pulmonary and intestinal worm burdens were being determined, blood was collected from aortae of sacrificed animals and left to clot for 2 h at 4 ˚C and then centrifuged for 15 min at 13, 000 g. The sera were collected and stored at -20 ˚C until immunoglobulin G subclasses were assayed by ELISA. 
Analysis of IL4-and γ-IFN-mRNAs in skin samples
The skin sites of infection were removed and snap frozen in liquid nitrogen until required. Skin samples were homogenised in 1 ml RNA STAT-60™ (Biogenesis) per 100 mg of tissue in a glass-Teflon homogeniser and total RNA was isolated as recommended by the manufacturer. The RNA was resuspended in diethylpyrocarbonate-treated water and quantitated spectrophotometrically.
The levels of IL4-and γ-IFN-mRNAs in extracted RNA from nonvaccinated/infected and vaccinated/infected individual animals were determined in relation to the mRNA of the housekeeping gene β-actin using the Promega Access RT-PCR System (Promega). The PCR products were electrophoresed on 2 % (w/v) agarose gels, stained with ethidium bromide (Sambrook et al., 1989) and photographed under UV light.
IL4 and γ-IFN production by cultured lymphocytes
Axillary lymph nodes were removed from non-vaccinated/infected and vaccinated/infected animals and individually dissociated in lymphocyte culture medium (LCM) containing RPMI, 10 % FCS, 100 U/ml penicillin, 100 µg/ml streptomycin and 2 % L-glutamine. Collected cells were washed into 25 ml LCM and centrifuged for 7 min at 1 300 r.p.m. The cells were then resuspended in 1 ml LCM, counted using trypan blue (Sigma), and adjusted to 2.5 x 10 6 cells /ml; 200 µl of cell suspension were then aliquoted into 96-well plates and stimulated by the addition of 5 µg/ml concanavalin A (ConA, Sigma). After 3 days incubation at 37 ˚C, 100 µl of supernatant were removed from each well, and stored at -20 ˚C until required for the cytokine assays.
IL4 and γ-IFN were measured using a capture ELISA (DuoSET ELISA Development System kit, R&D Systems) following the manufacturer's instructions, using cytokine standards (0-1000 pg/ml for IL4; 0-2000 pg/ml for γ-IFN) for quantification. Biotin labelled detection antibodies were used, revealed with streptavidin-HRP and a TMB substrate system.
Mast cell staining
The cutaneous responses following infection with N. americanus were studied in vaccinated/infected, non-vaccinated/infected and naïve BALB/c mice. The skin sites of vaccination and/or infection from four mice of each group (or dorsal skin patches in the case of naïve controls) were excised and fixed in 10 % (v/v) neutral buffered formaldehyde. Tissues were processed using the Shandon Hypercentre and then embedded in paraffin wax using conventional techniques. Transverse skin sections of 10 µm thickness were then produced using a rotary Leitz microtome and the sections stained with 0.6 % (v/v) aqueous thionin blue using techniques described by Humason (1979) .
Lung pathology
The pulmonary responses following infection with N. americanus were studied in vaccinated/infected, non-vaccinated/infected and naïve BALB/c mice. The lungs from four mice of each group were excised, fixed and sectioned as described above (section 2.8). Transverse lungs sections were stained with haematoxylin and eosin.
Statistical analysis
Student's t-test was used to assess potential differences in worm burden, cytokine secretion by activated lymphocytes and serum antibody isotype levels between experimental groups, normal distribution of the data having been established first.
Where the direction of a difference between two groups was unknown, a 2-tailed ttest was used; in others cases a 1-tailed analysis was implemented. Where appropriate, when multiple groups are involved, the Bonferroni procedure was used to choose the individual error rate for the null hypothesis (Morrison, 2002) . Table 1 , experiment 2, shows that significant protection against challenge infection was achieved in BALB/c mice following two percutaneous vaccinations, reducing significantly (p < 0.01) the worm burden by 57 % in the lungs and 100 % in the small intestine.
Results
Protection induced by gamma-irradiated larval vaccine
Effects of infection and vaccination on the skin Mast cell responses in the skin
Following infection of non-vaccinated animals, a small increase in mast cell number was observed compared with that of the naïve tissue (Fig 1a, b) , within which mast cells were sparse. Mast cell granules were observed in both naïve and non-vaccinated tissue. In the vaccinated tissue, an increased number of mast cells (Fig 1c) was observed compared with the non-vaccinated and naïve animals. These mast cells were accumulated mainly in the innermost part of the dermis and were degranulated.
Mast cell numbers were quantified on days 1, 3 and 8 p.i. (Fig 2) . corresponds to the IL4 gene product; the intensity of this band was greater in the vaccinated/infected group than in the non-vaccinated/infected group. A feint amplification product of similar intensity of about 400 bp corresponding to γ-IFN mRNA could be detected in both skin samples (lanes 4 and 7).
Analyses of γ-IFN and IL4 production by lymphocytes isolated from skin draining lymph nodes (axillary lymph nodes) of non-vaccinated/infected and vaccinated/infected animals, on days 3, 8 and 15 p.i. are shown in Table 2 . Mean levels of secreted IL4 in the vaccinated/infected group were consistently much higher than in the non-vaccinated/infected group and was significantly highest at 8 days p.i.
Levels of γ-IFN were generally slightly higher in the vaccinated/infected animals compared with the non-vaccinated/infected group. Overall, the IL4/γ-IFN ratio was higher in the axillary lymph nodes tissues of vaccinated/infected mice compared with the non-vaccinated/infected group, particularly at 8 days p.i.
Effects of infection and vaccination on the lungs
The effect of vaccination on larval migration was studied by monitoring the number of worms recovered from the lungs of non-vaccinated/infected and vaccinated/infected animals on days 1-5, 7-10 following infection (Fig 4) . Whilst worms started appearing in the lungs of the non-vaccinated animals 2 days after infection, no worms were detected in the lungs of vaccinated animals until 3 days after infection. Furthermore, the mean number of worms recovered from the vaccinated animals was reduced compared with the number of worms recovered from the lungs of non-vaccinated animals (39 compared with 62 worms). 
Antibody responses induced in vaccinated animals
Serum samples from naïve, non-vaccinated/infected and three times percutaneously vaccinated/infected animals were used to examine the IgG subclass response to vaccination and subsequent infection with N. americanus (Fig 6) . The worm burden data are presented in Table 1 , experiment 1. Significantly higher levels of IgG1 were observed in the vaccinated/infected animals compared with naïve and nonvaccinated/infected mice on day 0, 3 and 8 p.i). However, IgG1 levels in the vaccinated animals were statistically lower at days 3 and 8 p.i.. than at day 0 (P < 0.001). IgG3 levels were highest in the vaccinated group, rising markedly after infection. Between days 3 and 8 there was also a significant (P < 0.005) increase in IgG3 levels in the non vaccinated/infected group. IgG2a levels were also raised, to a lesser extent, in the vaccinated group but IgG2b levels remained low and did not differ significantly between groups throughout.
Discussion
In the fight against infectious diseases, most successful vaccines developed have used attenuated organisms. Attenuated vaccine models have been studied in detail for numerous parasites, including S. mansoni (Mountford et al., 1988; Pemberton et al., 1991) ; however, little is known about responses to such vaccines for N. americanus (Ghosh and Hotez, 1999; Sen et al., 2000) . It is recognised that attenuated vaccines are unlikely to be the basis for a completely safe and successful human vaccine against N. americanus. Notwithstanding, an understanding of the immune response induced by γ-irradiated larvae will assist in the design of an acceptable human vaccine in terms of understanding the protective phenotype which need to be induced, which also has a bearing on the type of adjuvant chosen. The present paper describes the level of protection afforded, and the nature of the immune response induced, by the use of irradiated larvae against subsequent N. americanus infection in BALB/c mice.
The data presented demonstrate that complete protection against challenge infection was achieved following three vaccinations with 300 γ-irradiated larvae. It has also been shown that fewer than three immunisations may be sufficient to achieve a high level of protection against challenge infection, as two percutaneous immunisations with irradiated larvae led to 98 % protection in the intestine and 57 % protection in the lungs following infection. It is therefore possible (but not tested here) that a single immunisation with attenuated organisms may also confer significant protection against N. americanus infection. It has been reported elsewhere, for example, that a single exposure to 500 attenuated cercariae induces 60-70% protection in C57BL/6 mice against schistosomes (Dean, 1983) . Hsu et al. (1983) The antibody analysis also demonstrated that vaccination induced a Th2 response characterised by the production of IgG1 (a serological marker of the Th2 response).
High levels of IL5 (a Th2 cell marker) were also observed in mice vaccinated with attenuated "Necator" larvae (Brown, A., 2000. Necator americanus: characterisation of secreted proteinases and vaccine development. PhD, The Nottingham Trent University). This supports the previous analyses done in human populations by Pritchard et al. (1995) on IgE production which showed a negative relationship between IgE (Th2 marker) and parasite weight and fecundity. Another concern regarding the development of a Th2 response was that it could be responsible for immune-mediated pathology (Finkelman and Urban, 1992) . However, although the lungs of non-vaccinated/infected animals presented severe generalised haemorrhage, caused by the passage of "Necator" larvae into the lungs, rupturing pulmonary capillaries, little or no pathology was observed in the lungs of vaccinated animals. In addition, the passage of infective larvae into the lungs of vaccinated/infected animals was delayed compared with that of non-vaccinated/infected animals. These combined data suggest that a Th2 response is responsible for the development of an acquired immunity in the vaccinated/infected animals and not responsible for the development of immuno-pathology. The fact that IgG1 levels were reduced in vaccinated animals three days after infection may indicate that the live infective larvae (unlike attenuated larvae) were moderating the Th2 response. Indeed the increase in IgG3 with time p.i.
in both vaccinated and non-vaccinated groups would support this suggestion. 
